Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
News Source : Financial Post
News Summary
- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX) will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025 at 1:00 p.m.
- ET, which will be available via webcast.
- PEDMARK received FDA approval in September 2022 and European Commission approval in June 2023 and United Kingdom (U.K.) approval in October 2023 under the brand name PEDMARQSI.
RESEARCH TRIANGLE PARK, N.C., Nov. 26, 2025 (GLOBE NEWSWIRE) Fennec Pharmaceuticals Inc. (NASDAQ FENC; TSX FRX), a commercial stage specialty pharmaceutical company, today announced that the Compan [+4047 chars]
Never miss a story from us, subscribe to our newsletter